Physician profile
Ashesh Buch
NPI 1114287117
$14,114.89
in general payments reported to CMS, 2019-2025
22 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $169 · 2021: $2,166 · 2022: $5,813 · 2023: $5,174 · 2024: $417 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $1,266 · Travel and Lodging: $40.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $1,266.27 |
| Travel and Lodging | $40.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $4,838.00 | 2020-2023 | Diamondback Coronary |
| Abbott Laboratories | $4,693.42 | 2019-2025 | Diamondback Coronary, Cardiomems, Amplatzer Amulet |
| Philips North America LLC | $2,636.43 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Boston Scientific Corporation | $234.16 | 2019-2025 | Avvigo Guidance System, Opticross |
| Shockwave Medical, INC | $179.15 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $174.57 | 2021 | |
| Cvrx, INC. | $153.86 | 2024 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.99 | 2019-2024 | Lifevest |
| Ge Healthcare | $148.35 | 2020 | |
| Chiesi USA, INC. | $138.66 | 2022-2025 | Kengreal, Cleviprex |
| Astrazeneca Pharmaceuticals LP | $135.07 | 2021-2022 | |
| Livanova USA, INC. | $109.84 | 2023 | Lifesparc |
| Novartis Pharmaceuticals Corporation | $96.22 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $80.16 | 2022 | |
| Vital Connect, INC | $64.17 | 2023 | Vitalpatch Rtm |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $63.73 | 2021-2022 | |
| Biotronik INC. | $63.25 | 2024-2025 | Zero Gravity, Acticor 7 Vr-T Dx |
| Cordis US Corp. | $55.36 | 2023 | Zephyr, Rain Sheath Transradial |
| Heartflow, INC. | $40.50 | 2025 | |
| Bridgebio Pharma, INC. | $29.54 | 2025 | Attruby |
| Irhythm Technologies, INC. | $15.89 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashesh Buch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.